Triazenes: Chemical, Biological, And Clinical Aspects-..

Código: 1067427 Marca:
R$ 456,42 R$ 365,14
até 4x de R$ 91,28 sem juros
ou R$ 346,88 via Pix
Adicionar ao carrinho Disponibilidade: 45 dias úteis Estoque: 144 unidades
    • 1x de R$ 365,14 sem juros
    • 2x de R$ 182,57 sem juros
    • 3x de R$ 121,71 sem juros
    • 4x de R$ 91,28 sem juros
  • R$ 346,88 Pix
  • R$ 365,14 Boleto Bancário
* Este prazo de entrega está considerando a disponibilidade do produto + prazo de entrega.
More than 25 years have elapsed since the development of the seminal idea which led to the synthesis of dimethyl triazenes as antitumor agents. The original suggestion of Shealy et ale was to use 4-imidazone-carboxarnide as the carrier of a nitro- gen-containing cytotoxic function. 5-diazoimidazole-4-carbox- amide (diazo-IC) was synthesized and tested in mice as a potential inhibitor of de novo purine biosynthesis. Its lack of antitumor action was attributed to its polarity and to the resulting poor uptake of this hydrophilic chemical. Diazo-IC was then coupled with dimethylamine, yielding 5, (3,3-dimethyl- l-triazeno)imidazole-4-carboxamide) (DTIC) with the intention of obtaining a less polar and more lipophil c prod rug which might release diazo-IC intracellularly. Preliminary tests showed that DTIC had good antiumor activity in experimental systems. Further tests demonstrated a broad spectrum of action against rodent tumors, and clinical trials indicated activity against human malignancies. Subsequent clinical use of DTIC has demonstrated its usefulness against malignant melanoma, for which it is currently the drug of choice, and its effective- ness in combination chemotherapy in the treatment of other human cancers. Because of its antitumor activity the mechan- ism of action of DTIC has been investigated in some detail. The original rationale for its development, that is, the hydrolysis in vivo to diazo-IC, has been shown not to be in- volved in th-e-mechansims of action. DTIC requires metabolic acti- vation before it exerts its biological effects.
ISBN 9781461367109
Autor(a) Giraldi, Tullio
Editora Springer Publishing
Ano de edição 2012
Páginas 227
Acabamento Brochura
Dimensões 24,40 X 17,00

Produtos relacionados

R$ 456,42 R$ 365,14
até 4x de R$ 91,28 sem juros
ou R$ 346,88 via Pix
Adicionar ao carrinho Disponibilidade: 45 dias úteis Estoque: 144 unidades
Pague com
  • proxy-pagali-v2
  • Pix
Selos
  • Site Seguro

MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026


Para continuar, informe seu e-mail

Utilizamos cookies para que você tenha a melhor experiência em nosso site. Para saber mais acesse nossa página de Política de Privacidade